Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Amgen
(NQ:
AMGN
)
315.12
+0.58 (+0.18%)
Streaming Delayed Price
Updated: 10:13 AM EDT, May 21, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Amgen
< Previous
1
2
...
30
31
32
33
34
35
36
37
Next >
Making a Difference When You Invest? Medexus Says It Improves Lives
November 10, 2021
Photo by Hernan Pauccara from Pexels The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial...
Via
Benzinga
This Company Says Its New Topical Therapy Trials Bringing Hope to People Exposed to Biofilm Bacteria
November 09, 2021
Photo by Louis Reed on Unsplash The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner...
Via
Benzinga
How Are Biotech ETFs Reacting To These Q3 Earnings Releases?
November 06, 2021
There's no denying that the pandemic has opened up investment opportunities in the biotech sector by triggering a race to introduce vaccines. Let’s take a look at big biotech earnings releases to see...
Via
Talk Markets
Where Amgen Stands With Analysts
November 03, 2021
Within the last quarter, Amgen (NASDAQ:AMGN) has observed the following ana...
Via
Benzinga
Amgen Q3 Earnings Saved By Higher Volumes Despite Pricing Pressure On Some Drugs
November 03, 2021
Amgen Inc's (NASDAQ: AMGN) Q3 revenues increased 4% to $6.71 billion, slightly beating the consensus of $6.68 billion. The increase is driven by higher unit demand...
Via
Benzinga
CNBC's Final Trades: Amgen, Marriot And Mastercard
November 01, 2021
On CNBC’s “Halftime Report Final Trades,” Car...
Via
Benzinga
Expert Ratings For Amgen
October 12, 2021
Amgen (NASDAQ:AMGN) has observed the following analyst ratings within the ...
Via
Benzinga
The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termination Of J&J Licensing Deal, Amgen Migraine Drug Data
November 09, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck Gets Antitrust Nod For Acceleron Deal In Germany, Austria, Announces...
Via
Benzinga
A Peek Into The Markets: US Stock Futures Mixed; All Eyes On Fed Decision
November 03, 2021
Pre-open movers U.S. stock futures traded mixed in early pre-market trade after settling at another record highs in the previous session. The Federal Reserve will announce its...
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
5 Stocks To Watch For November 3, 2021
November 03, 2021
Some of the stocks that may grab investor focus today are: Wall Street expects CVS Health Corp (NYSE: CVS) to report quarterly earnings at $1.77 per share on revenue of $70.49...
Via
Benzinga
Amgen Inc. (AMGN) Q3 2021 Earnings Call Transcript
November 03, 2021
AMGN earnings call for the period ending October 31, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Amgen: Q3 Earnings Insights
November 02, 2021
Amgen (NASDAQ:AMGN) reported its Q3 earnings results on Tuesday, November 2, 2021 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Amgen their...
Via
Benzinga
Amgen Dips Despite Third-Quarter Beat With Sales Guidance Just In Line
November 02, 2021
Amgen stock fell late Tuesday after the company beat third-quarter forecasts, but 2021 sales guidance was just in line with estimates.
Via
Investor's Business Daily
Healthcare Stocks Subject to Government Policy
November 02, 2021
The market this morning isn’t moving much, but today’s tepid start is coming on the heels of yesterday’s record closes on the Dow, the S&P 500, and the...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
The Daily Biotech Pulse: Pfizer Reports Solid Q3 Earnings, Regulatory Setback For Legend, Lilly to Supply Additional COVID-19 Antibody Cocktails To US
November 02, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus SAB Spikes On Analyst Action SAB Biotherapeutics, Inc. (NASDAQ: SABS) shares...
Via
Benzinga
Exposures
COVID-19
Mirati Therapeutics COO, CMO Exit, Completing Management Overhaul
November 01, 2021
Shares of Mirati Therapeutics, Inc. (NASDAQ: MRTX) are retreating sharply Monday following two executive departures. What Happened: Mirati, a clinical-stage targeted oncology...
Via
Benzinga
Amgen's Earnings Outlook
November 01, 2021
Amgen (NASDAQ:AMGN) is set to give its latest quarterly earnings report on Tuesday, 2021-11-02. Here's what investors need to know before the announcement. Analysts estimate that...
Via
Benzinga
Carter Worth Says This Stock Is 'So Bad That It Is Good'
November 01, 2021
On CNBC's "Options Action," Carter Worth...
Via
Benzinga
5 Stocks Getting Crushed - Are They Buying Opportunities?
October 23, 2021
Five dividend growth stocks that are down at least 20% from highs.
Via
Talk Markets
Danielle Shay Expects This Dow Laggard To Hit New Highs
October 22, 2021
On CNBC’s "Trading Nation
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Clorox and Church & Dwight versus Amgen and Bristol-Myers Squibb
October 21, 2021
Base your stock investment decisions on fundamental values rather than short-term price activity.
Via
Talk Markets
Economic Reports Reflect Labor Shortages and Moderate Economic Growth
October 21, 2021
Stock futures are slightly lower as another large group of companies report earnings on Thursday. Starting with a surprise from AT&T (NYSE: T), the company is...
Via
Benzinga
The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline
October 31, 2021
Biotech stocks rose a third week running in the week ending Oct. 29 amid positive reaction to earnings. Big pharma earnings were mostly better than expected. Merck & Co, Inc...
Via
Benzinga
AstraZeneca Pulls Plug On MCL-1 Cancer Drug Trial
October 20, 2021
AstraZeneca Plc (NASDAQ: AZN) has paused an active Phase 1 trial of AZD5991, a direct inhibitor of MCL-1, citing a potential safety issue. Two years ago, the FDA hit ...
Via
Benzinga
Exposures
Product Safety
3 Biopharma Stocks To Watch Following Johnson & Johnson's Earnings Beat
October 19, 2021
Johnson & Johnson (NYSE:JNJ) shares are higher Tuesday fo...
Via
Benzinga
Esperion Chops 40% Workforce As Launch Of Cholesterol Medication Falters
October 18, 2021
Esperion Therapeutics Inc's (NASDAQ: ESPR) cholesterol drug marketing strategy has soured badly, as it has been struggling to sell its heart disease pill for more than a...
Via
Benzinga
Crispr: A Fallen Angel In Gene Editing
October 16, 2021
As with most promising biotech companies, investors bid their prices up for CRSP based on its potential for early profits. When the payoff didn't occur on schedule, investors bailed out. Once it...
Via
Talk Markets
How to Find Stocks on Sale in 2021
October 13, 2021
Despite the major stock indexes trading not far off their highs, some stocks have sold off and are now trading near their 52-week lows. Could there be some deals among those that are being discarded by...
Via
Talk Markets
The Daily Biotech Pulse: NRx Stitches COVID-19 Drug Partnership, Protara Gets Nod For Starting Bladder Cancer Study, IGM Moves Beyond Oncology
October 12, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 11) AstraZeneca Plc (NASDAQ:...
Via
Benzinga
Exposures
COVID-19
3 High-Yielding Dividend Stocks Trading Near Their 52-Week Lows
October 08, 2021
They may not be growth machines, but these stocks can generate a whole lot of dividend income for you.
Via
The Motley Fool
< Previous
1
2
...
30
31
32
33
34
35
36
37
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.